Korro also announced that David Lucchino has stepped down from the Board. Dr. Knobil brings a wealth of experience in clinical CAMBRIDGE, Mass., Aug. 27, 2024 (GLOBE NEWSWIRE) -- Korro Bio ...

In addition to the CEO's award, each non-employee director, namely David Eansor, Katherine Knobil, and Steven Elms, received a discretionary award of 30,000 stock options. These options are also ...

根据最新的SEC文件显示，总部位于德克萨斯州休斯顿的Marker Therapeutics, Inc. (NASDAQ: MRKR )——一家专注于癌症治疗开发的制药公司，已向其首席执行官和多位非雇员董事授予股票期权。该公司目前保持着良好的资产负债表，现金多于债务，流动比率达3.15，但在当前具有挑战性的市场环境下，其股票价格接近52周低点。

In addition to the CEO's award, each non-employee director, namely David Eansor, Katherine Knobil, and Steven Elms, received a discretionary award of 30,000 stock options. These options are also set ...

Respiratory function is modulated by circulating steroid hormones. In female rats, steroid hormones fluctuate across the normal estrous cycle and decline with age, similar to human menopause. To ...